NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

35.97

+0.45 (1.27%)

At close: Dec 4, 2025, 4:00 PM EST

35.85

-0.12 (-0.33%)

After-hours: Dec 4, 2025, 5:41 PM EST

NAMS Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	4,079	2,751	920	889	139	-
Market Cap Growth	77.30%	199.19%	3.44%	537.58%	-	-
Enterprise Value	3,309	2,329	501	796	144	-
Last Close Price	35.85	25.70	11.17	10.90	9.75	-
PS Ratio	115.24	60.38	65.26	8.66	-	-
PB Ratio	5.57	3.63	3.19	2.07	2.46	-
P/TBV Ratio	5.59	3.64	3.19	2.07	2.46	-
P/FCF Ratio	-	-	-	85.12	-	-
P/OCF Ratio	-	-	-	83.36	-	-
EV/Sales Ratio	93.90	51.12	35.56	7.75	-	-
EV/FCF Ratio	-	-	-	76.18	-	-
Debt / Equity Ratio	0	0.00	0	0	0.00	-3.26
Debt / FCF Ratio	-	-	-	0.01	-	-
Asset Turnover	0.06	0.08	0.03	0.38	-	-
Quick Ratio	12.41	8.00	6.86	13.03	5.81	0.61
Current Ratio	12.57	8.07	6.95	13.26	5.96	0.72
Return on Equity (ROE)	-39.94%	-46.20%	-49.25%	-9.30%	-159.01%	-
Return on Assets (ROA)	-20.70%	-18.19%	-27.70%	-0.81%	-55.71%	-
Return on Capital (ROIC)	-22.90%	-21.06%	-31.82%	-0.91%	-66.25%	-
Return on Capital Employed (ROCE)	-27.90%	-23.30%	-61.60%	-0.80%	-61.60%	151.80%
Earnings Yield	-5.44%	-8.78%	-19.24%	-2.55%	-29.97%	-
FCF Yield	-3.56%	-5.79%	-15.36%	1.18%	-21.18%	-
Buyback Yield / Dilution	-25.71%	-14.84%	-333.20%	-72.75%	-119.58%	-

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q